- Details
- Written by Matthias Bischoff
- Category
The Beethoven’s deafness and its development are a riddle. In a previous article the authors (Luthe and Bischoff, 2020) suggested poisoning by ultrafine particles through lead corrosion of e.g. organ pipes. In the present article, they propose that Beethoven’s health problems, especially his deafness, were caused by a combination of exposure to lead-containing micro- and nanoparticles. In addition, high alcohol consumption weakened the defense against radical oxidative stress. The authors further hypothesize that the ear is a major portal of entry for nanoparticles, in this case causing lead poisoning of the inner ear.
- Details
- Written by Matthias Bischoff
- Category
In this article the authors (Luthe and Bischoff, 2020) connect recent findings in nano-toxicology with the investigations in Ludwig van Beethoven’s supposed saturnism. Namely, contradicting measurements of lead concentration in Beethoven’s hair and bone cannot be explained by the current hypothesis discussed among scientists. This mismatch may be called the key to the conundrum. It is also of broader interest to toxicologists, as the circumstances of Beethoven’s poisoning elucidate a general issue of particle uptake and resulting effects, which is quite neglected until now. They suggest that lead containing micro- and nanoparticles, i.e. lead oxides and acetate are the basis for the contradicting lead levels. The different portal of entry discriminates the concentrations in the bones when compared to the hair follicles. The authors also consider the source for these ultrafine lead-containing particles in Beethoven’s environment, and propose a complete explanation for his saturnism.
- Details
- Written by Max-Planck-Institut für molekulare Biomedizin
- Category
Max Planck Innovation licenses process for the generation of organ-like tissue aggregates to biotech company StemoniX
***Sometimes hundreds of thousands of potential therapeutics need to be tested in large-scale, fully automated experiments to identify a single effective drug. Most compounds do not work as desired, and some are even toxic. Since the development of the induced Pluripotent Stem (iPS) Cell technology in 2006, researchers have been able to produce stem cells from skin biopsies and blood samples. To approach physiological conditions in the laboratory, many researchers use iPS cell technology to produce three-dimensional, organ-like tissue aggregates (organoids).
- Details
- Written by Julius-Maximilians-Universität Würzburg
- Category
Researchers at the universities of Würzburg and Frankfurt have developed a new compound for treating cancer. It destroys a protein that triggers its development.
The villain in this drama has a pretty name: Aurora – Latin for dawn. In the world of biochemistry, however, Aurora (more precisely: Aurora-A kinase) stands for a protein that causes extensive damage. There, it has been known for a long time that Aurora often causes cancer. It triggers the development of leukemias and many pediatric cancers, such as neuroblastomas.